Wang, M., Chen, P., Jia, Y., He, N., Li, D., Ji, C., & Ma, D. (2015). Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma. Oncotarget.

Wang, Min, Ping Chen, Yan Jia, Na He, Daqi Li, Chunyan Ji, and Daoxin Ma. "Elevated Th22 As Well As Th17 Cells Associated With Therapeutic Outcome and Clinical Stage Are Potential Targets in Patients With Multiple Myeloma." Oncotarget 2015.

Wang, Min, et al. "Elevated Th22 As Well As Th17 Cells Associated With Therapeutic Outcome and Clinical Stage Are Potential Targets in Patients With Multiple Myeloma." Oncotarget 2015.